General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Myokardia(SIGNIFICANT), Cytokinetics(SIGNIFICANT), Pfizer(MODEST), Renovacor (MODEST), Bristol Myers Squibb(SIGNIFICANT), Stealth Biotherapeutics(MODEST), Lexicon(MODEST), Tenaya Therapeutics(MODEST), Lexeo Therapeutics(MODEST), BioMarin Pharmaceuticals(MODEST), Edgewise Therapeutics(MODEST), Alexion(SIGNIFICANT), Corvista(NONE) RESEARCH/RESEARCH GRANTS: Array Biopharma(NONE), Bristol-Myers Squibb Company (SIGNIFICANT)

View Full Disclosure